EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Effect of dexamethasone therapy in Crimean-Congo hemorrhagic fever in Giresun: An analytical study

Sinan Çetin, Ahmet Melih Şahin, Emrullah Ataş, Emsal Aydın, İlknur Şenel, Meltem Arzu Yetkin

Journal of Vector Borne Diseases · 2025

DOI: 10.4103/jvbd.jvbd_95_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vector Borne Diseases, 2025. Verfasst von Sinan Çetin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Giresun University, Giresun, Turkey. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Crimean, Dexamethasone. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives: Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic disease and significant health concern particularly in endemic regions. We aimed to evaluate the efficacy in dexamethasone treatment on clinical outcomes in CCHF patients.

Methods

We included adult patients diagnosed with CCHF and those whose platelet count dropped to 70,000/mm 3 or lower. The efficacy of dexamethasone on clinical outcomes was evaluated. It was a retrospective analytical study.

Results

All 55 patients received standard supportive treatment, and none of them received ribavirin therapy. It was observed that 23 (41.8%) patients were treated with dexamethasone. No significant differences were observed between patients treated with dexamethasone and without, regarding factors such as bleeding incidents during hospitalization, the need for blood product transfusions, thrombocyte recovery status, intensive care unit admission, and in-hospital mortality. In-hospital mortality was observed in two patients (3.6%). Interpretation & conclusion: Our study found that dexamethasone treatment did not lead to a significant improvement in the clinical outcomes for CCHF patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemorrhagic Fever, CrimeanDexamethasoneHumansFemaleRetrospective StudiesMaleMiddle AgedTreatment OutcomeAdultAgedPlatelet CountAntiviral AgentsHemorrhagic Fever Virus, Crimean-Congo

Stichwörter der Autor:innen

CorticosteroidCrimean-Congo hemorrhagic fever (CCHF)dexamethasone

Substanzen

DexamethasoneAntiviral Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Giresun University, Giresun, Turkey.

Zitieren

APA

Çetin, S., Şahin, A. M., Ataş, E., Aydın, E., Şenel, İ., & Yetkin, M. A. (2025). Effect of dexamethasone therapy in Crimean-Congo hemorrhagic fever in Giresun: An analytical study. Journal of Vector Borne Diseases. https://doi.org/10.4103/jvbd.jvbd_95_24

Vancouver

Çetin S, Şahin AM, Ataş E, Aydın E, Şenel İ, Yetkin MA. Effect of dexamethasone therapy in Crimean-Congo hemorrhagic fever in Giresun: An analytical study. Journal of Vector Borne Diseases. 2025. doi:10.4103/jvbd.jvbd_95_24

BibTeX
@article{etin2025,
  author = {Çetin, Sinan and Şahin, Ahmet Melih and Ataş, Emrullah and Aydın, Emsal and Şenel, İlknur and Yetkin, Meltem Arzu},
  title = {Effect of dexamethasone therapy in Crimean-Congo hemorrhagic fever in Giresun: An analytical study},
  journal = {Journal of Vector Borne Diseases},
  year = {2025},
  doi = {10.4103/jvbd.jvbd_95_24}
}
Kostenlos starten →